Author | Julia Ernst, MS

Articles

LED Device May Offer Psoriasis Patients a More Individualized Treatment Option

November 03, 2014

Article

A light-emitting diode (LED) device that uses 40 high-intensity blue LEDs, which can be configured to an individual patient's needs, and is free of ultraviolet (UV) light, may offer a new treatment option for patients with psoriasis.

Secukinumab Takes Another Step Toward FDA Approval

October 31, 2014

Article

The compound AIN457 (secukinumab) has been granted a unanimous vote of support for approval from the Dermatologic and Ophthalmic Drugs Advisory Committee to the Food and Drug Administration.

Plaque Psoriasis Drug Candidate Shows Positive Top-Line Results in First of Two Phase III Studies

October 31, 2014

Article

Amgen has released positive top-line results from the first of two Phase III studies of ABP 501, its candidate for the treatment of moderate-to-severe plaque psoriasis that is being developed as a biosimilar to adalimumab.

Psoriasis News and Updates

October 16, 2014

Article

News from the literature on a possible link between atherosclerosis and psoriasis and quality of life for patients with this skin condition.

x